AMBARELLA INC AMBA
Nasdaq · XNAS · stock · Semiconductors & Related Devices
Chart by TradingView
4/9
Piotroski F — financial health
2.94
Altman Z″ — distress risk · safe
—
Dividend payout · no dividend
Financials (annual, from 10-K)
| FY | Revenue | Net income | Gross profit | Free cash flow | Equity |
|---|---|---|---|---|---|
| 2026 | $390.7M | -$75.9M | $231.3M | — | $594.8M |
| 2025 | $284.9M | -$117.1M | $172.3M | — | $561.4M |
| 2024 | $226.5M | -$169.4M | $136.8M | — | $559.9M |
| 2023 | $337.6M | -$65.4M | $208.9M | — | $606.1M |
| 2022 | $331.9M | -$26.4M | $208.1M | — | $547.2M |
| 2021 | $223.0M | -$59.8M | $135.6M | $28.8M | $475.0M |
Why these scores methodology →
Piotroski F-score: 4/9
- Positive return on assets
- Positive operating cash flow
- Rising ROA
- Cash flow exceeds net income
- Lower long-term debt
- Rising current ratio
- No share dilution
- Rising gross margin
- Rising asset turnover
Altman Z″: 2.94 (safe)
- Working capital / assets 0.291
- Retained earnings / assets -0.411
- EBIT / assets -0.103
- Equity / liabilities 2.918
Source: SEC EDGAR filings · CIK 0001280263 · as of 2026-01-31. Figures are facts from filings plus Stocktoria's own computed scores — not investment advice.